Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Aug 31;29(11):2369–2375. doi: 10.1158/1055-9965.EPI-20-0564

Table 1.

Demographic and clinical characteristics of study participants

Detroit ROCS
n=171
Age (years) n (%)
<50 62 34.3%
50–59 43 23.8%
60–69 59 32.6%
70+ 17 9.4%
Stage
I 71 39.2%
II 72 39.8%
III 31 17.1%
IV 7 3.9%
Grade
1 19 10.5%
2 70 38.7%
3 82 45.3%
Unknown 10 5.5%
Family history of breast cancer
Yes 52 28.6%
No 130 71.4%
Subtype
ER−/PR−/HER2+ 14 7.7%
ER+ or PR+, HER2− 102 56.4%
ER+ or PR+, HER2+ 24 13.3%
Triple negative 34 18.8%
Unknown 7 3.9%